The Association of Dysglycaemia and Cardiovascular Disease in Patients with Metabolic Syndrome

Author： Gong W   Yang Z   Ye W   Du Y   Lu B   Wang M   Li Q   Zhang W   Pan Y   Feng X   Zhou W   Zhang Y   Wen J   Yang Z   Yang Y   Zhu X   Hu R  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.37, Iss.5, 2009-09, pp. : 1486-1492

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pathophysiology and Therapeutics of Cardiovascular Disease in Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 19, Iss. 27, 2013-08 ,pp. : 4799-4805

Bentham Science Publishers

Access to resources Recommend Favorite

Determinants of Increased Cardiovascular Disease in Obesity and Metabolic Syndrome

By  

Current Medicinal Chemistry, Vol. 18, Iss. 34, 2011-12 ,pp. : 5267-5280

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-01 ,pp. : 5025-5038

Bentham Science Publishers

Access to resources Recommend Favorite

Sufficient Weight Reduction Decreases Cardiovascular Complications in Diabetic Patients with the Metabolic Syndrome

By  

Heart Drug, Vol. 5, Iss. 2, 2005-03 ,pp. : 68-74

Karger

Access to resources Recommend Favorite

TA-65, A Telomerase Activator improves Cardiovascular Markers in Patients with Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 24, Iss. 17, 2018-05 ,pp. : 1905-1911

Bentham Science Publishers

Access to resources Recommend Favorite